Physician profile
Bryan Adam Schatmeyer
NPI 1699270629
$3,633.56
in general payments reported to CMS, 2019-2025
7 companies · $2,802 in 2025
The $2,802 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.02 · 2022: $179 · 2024: $589 · 2025: $2,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,462 · Food and Beverage: $896 · Education: $32.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,462.15 |
| Food and Beverage | $896.00 |
| Education | $32.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $2,745.48 | 2024-2025 | Xlif, Excelsiusgps Robotic Navigation System, Sable |
| Medtronic, INC. | $368.81 | 2024-2025 | Mazor X System, Midas Rex, Pivox Oblique Lateral Spinal System |
| Cerapedics INC. | $237.58 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Kuros Biosciences USA, INC | $157.18 | 2022 | |
| Depuy Synthes Sales INC. | $64.02 | 2019 | |
| Gt Medical Technologies, INC | $43.26 | 2022-2025 | Gammatile |
| Brainlab, INC. | $17.23 | 2025 | Brainlab, INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Schatmeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.